Initiation of Epigenetic Transcriptional Regulation
Initiation of Epigenetic Transcriptional Regulation
批准号:
8146517
负责人:
SUNDEEP KALANTRY
金额:
$233.25万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2016-06-30
关键词:
Cell divisionCellsChromosomesDNADNA Modification ProcessDNA SequenceDataDevelopmentDevelopmental ProcessDiseaseDisease ProgressionDissectionEmbryonic DevelopmentEpigenetic ProcessEventFemaleGene DosageGene ExpressionGene SilencingHistonesInheritedLinkMalignant NeoplasmsMammalsModelingModificationMolecularMolecular ProfilingMusMutationPatternPhasePolycombProteinsRNASumSystemTherapeuticTherapeutic InterventionTranscriptTranscriptional RegulationX ChromosomeX Inactivationabstractingbasehuman diseaseimprintmalenovelpreventpublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by the applicant)
Abstract: Cells retain their identity by inheriting and maintaining gene expression profiles of their predecessors. Patterns of gene expression that propagate through cell division are thought to be established and maintained in part through reversible covalent modifications of DNA and DNA-associated proteins (i.e., histones). These heritable patterns of gene expression do not involve changes in the DNA sequence and are termed 'epigenetic'. Emerging evidence implicates epigenetic inheritance in a myriad of developmental processes as well as being a significant contributor to human diseases. While many epigenetic modifications correlate with specific gene expression states, evidence supporting specific factors in initiating epigenetic control of gene expression remains scant. Finding the molecular basis of epigenetic triggers will elucidate how mitotically- heritable patterns of gene expression are established during development and disease. Moreover, due to the potential reversibility of epigenetic modifications, the identification of epigenetic initiators may provide key candidates for manipulating the transcriptional profile of cells for therapeutic purposes. We propose to comprehensively identify factors and mechanisms that initiate as well as prevent epigenetic transcriptional inactivation, through a groundbreaking approach in the study of X-chromosome inactivation. X-inactivation provides an experimentally tractable system for the dissection of epigenetic inheritance. X-inactivation results in the mitotically-heritable transcriptional inactivation of one X-chromosome in female mammals, thereby equalizing X-linked gene dosage between males and females. The epigenetic factors and mechanisms that execute X-inactivation are known to overlap with those that regulate embryonic development and disease progression (i.e., cancers). Thus, understanding the cascade of epigenetic events that characterizes the inactive- as well as the active-X offers a window into identifying the common factors that initiate and prevent epigenetic transcriptional inactivation during development and disease. Contrary to the prevailing models of X- inactivation initiation, we have established compelling evidence that the factors thought to trigger X- inactivation, Xist RNA and Polycomb group proteins, are both dispensable for the initiation of chromosome- wide X-linked gene silencing during mouse imprinted X-inactivation. We have also gathered data that indicates that the Xist anti-sense transcript Tsix, proposed to forestall inactivation of the active-X, is dispensable in preventing inactivation of the active X-chromosome during the initiation phase of imprinted X- inactivation. Moreover, proteins that prevent the epigenetic transcriptional inactivation of the active-X remain unknown. In sum, these findings imply that undiscovered epigenetic factors must exist to initiate as well as prevent X-inactivation, and is the focus of this proposal.
Public Health Relevance: This proposal aims to discover and delineate novel factors and mechanisms that trigger epigenetic transcriptional regulation. Dysregulation of the epigenetic cellular machinery is increasingly being recognized as a cause of, or significant contributor to, human diseases such as cancers. Importantly, as opposed to irreversible mutations in DNA, epigenetic modifications are reversible. This reversibility makes epigenetic changes, including those we propose to identify, potentially amenable to manipulation and therapeutic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating Novel Modes of Epigenetic Regulation Through the Polycomb Group
-
批准号:10406668
-
项目类别:
-
资助金额:$6.14万
-
财政年份:2021
-
负责人:SUNDEEP KALANTRY
-
依托单位:
Investigating Novel Modes of Epigenetic Regulation Through the Polycomb Group
-
批准号:10396014
-
项目类别:
-
资助金额:$41.56万
-
财政年份:2018
-
负责人:SUNDEEP KALANTRY
-
依托单位:
Investigating Novel Modes of Epigenetic Regulation Through the Polycomb Group
-
批准号:10614794
-
项目类别:
-
资助金额:$8.21万
-
财政年份:2018
-
负责人:SUNDEEP KALANTRY
-
依托单位:
Investigating Novel Modes of Epigenetic Regulation Through the Polycomb Group
-
批准号:9922974
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2018
-
负责人:SUNDEEP KALANTRY
-
依托单位:
X-chromosome Inactivation Catalyzed by Genes That Escape X-inactivation
-
批准号:9376535
-
项目类别:
-
资助金额:$40.95万
-
财政年份:2017
-
负责人:SUNDEEP KALANTRY
-
依托单位:
X-chromosome Inactivation Catalyzed by Genes That Escape X-inactivation
-
批准号:9753029
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2017
-
负责人:SUNDEEP KALANTRY
-
依托单位:
X-chromosome Inactivation Catalyzed by Genes That Escape X-inactivation
-
批准号:9978593
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2017
-
负责人:SUNDEEP KALANTRY
-
依托单位:
X-chromosome Inactivation Catalyzed by Genes That Escape X-inactivation
-
批准号:9895268
-
项目类别:
-
资助金额:$18.51万
-
财政年份:2017
-
负责人:SUNDEEP KALANTRY
-
依托单位:
Epigenetic Mechanisms of X-chromosome Inactivation
-
批准号:7944096
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2009
-
负责人:SUNDEEP KALANTRY
-
依托单位:
Epigenetic Mechanisms of X-chromosome Inactivation
-
批准号:7924264
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:SUNDEEP KALANTRY
-
依托单位:
Epigenetic Mechanisms of X-chromosome Inactivation
-
批准号:8109229
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2009
-
负责人:SUNDEEP KALANTRY
-
依托单位:
Epigenetic Mechanisms of X-chromosome Inactivation
-
批准号:7244762
-
项目类别:
-
资助金额:$8.21万
-
财政年份:2007
-
负责人:SUNDEEP KALANTRY
-
依托单位:
Epigenetic Mechanisms of X-chromosome Inactivation
-
批准号:7405377
-
项目类别:
-
资助金额:$8.21万
-
财政年份:2007
-
负责人:SUNDEEP KALANTRY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: